Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
Authors
Keywords
-
Journal
CNS DRUGS
Volume 35, Issue 9, Pages 925-934
Publisher
Springer Science and Business Media LLC
Online
2021-08-07
DOI
10.1007/s40263-021-00846-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
- (2021) Orly Lipsitz et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
- (2021) Jason Ng et al. PSYCHOPHARMACOLOGY
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effect of Intravenous Ketamine on Cognitive Functions in Adults with Treatment-Resistant Major Depressive or Bipolar Disorders: Results from the Canadian Rapid Treatment Center of Excellence (CRTCE)
- (2021) Roger S. McIntyre et al. PSYCHIATRY RESEARCH
- Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
- (2020) Teodora Doherty et al. CNS DRUGS
- The Effectiveness of Ketamine on Anxiety, Irritability, and Agitation: Implications for Treating Mixed Features in Adults with Major Depressive or Bipolar Disorder
- (2020) Roger S. McIntyre et al. BIPOLAR DISORDERS
- Development of the Ketamine Side Effect Tool (KSET)
- (2020) Brooke Short et al. JOURNAL OF AFFECTIVE DISORDERS
- The Effectiveness of Repeated Intravenous Ketamine on Depressive Symptoms, Suicidal Ideation and Functional Disability in Adults with Major Depressive Disorder and Bipolar Disorder: Results from the Canadian Rapid Treatment Center of Excellence
- (2020) Roger S McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
- (2020) Nelson B. Rodrigues et al. Expert Opinion On Drug Safety
- Safety of Repeated Administration of Parenteral Ketamine for Depression
- (2020) David Feifel et al. Pharmaceuticals
- Dissociative and Analgesic Properties of Ketamine Are Independent
- (2020) Jacob Gitlin et al. ANESTHESIOLOGY
- Managing dissociative symptoms following the use of esketamine nasal spray
- (2020) Sophia Pereira et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
- (2020) Chiara Gastaldon et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions
- (2020) Nelson B. Rodrigues et al. JOURNAL OF AFFECTIVE DISORDERS
- The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
- (2020) Jiaqi Xiong et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
- (2019) Elia E. Acevedo-Diaz et al. JOURNAL OF AFFECTIVE DISORDERS
- Esketamine for treatment resistant depression: a trick of smoke and mirrors?
- (2019) C. Gastaldon et al. Epidemiology and Psychiatric Sciences
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
- (2018) Patricio Riva-Posse et al. JOURNAL OF AFFECTIVE DISORDERS
- Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
- (2018) Steven P. Cohen et al. REGIONAL ANESTHESIA AND PAIN MEDICINE
- Administration of ketamine for unipolar and bipolar depression
- (2017) Christoph Kraus et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
- (2017) David Feifel et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action
- (2017) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- Ketamine-Induced Apoptosis in Normal Human Urothelial Cells
- (2016) Simon C. Baker et al. AMERICAN JOURNAL OF PATHOLOGY
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review
- (2016) Matthew D. Cooper et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
- (2014) Le-Ben Wan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Hepatic effects of ketamine administration for 2 weeks in rats
- (2013) Y. Kalkan et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Side effects that Cause Noncompliance to Antidepressant Medications in the Course of Outpatient Treatment
- (2013) Adem Balsikci et al. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
- The prevalence and natural history of urinary symptoms among recreational ketamine users
- (2012) Adam R. Winstock et al. BJU INTERNATIONAL
- General Anesthesia and Altered States of Arousal: A Systems Neuroscience Analysis
- (2011) Emery N. Brown et al. Annual Review of Neuroscience
- Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: A report of 3 cases
- (2011) Ingeborg M. Noppers et al. PAIN
- Wherefore ketamine?
- (2010) Jan Persson Current Opinion in Anesthesiology
- Can ketamine prescribed for pain cause damage to the urinary tract?
- (2009) TM Storr et al. PALLIATIVE MEDICINE
- A Pediatric Case of Ketamine-associated Cystitis (Letter-to-the-Editor RE: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated Ulcerative Cystitis: A New Clinical Entity. Urology 69: 810–812, 2007)
- (2008) Marie-Claude Grégoire et al. UROLOGY
- Urinary tract disease associated with chronic ketamine use
- (2008) Angela M Cottrell et al. BMJ-British Medical Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started